The road to personalised medicine in psoriatic arthritis

Expert Rev Clin Immunol. 2021 Aug;17(8):799-802. doi: 10.1080/1744666X.2021.1931125. Epub 2021 May 31.

Authors

Jonathan P E White¹, Laura C Coates²

Affiliations

¹ Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Trust, Oxford, UK.
² Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, UK.

PMID: 34000952
DOI: 10.1080/1744666X.2021.1931125

No abstract available

Keywords: Psoriatic arthritis; biological DMARDs; immunophenotype; personalize medicine; precision medicine.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Psoriatic* / drug therapy
Arthritis, Psoriatic* / therapy
Biological Products* / therapeutic use
Humans
Precision Medicine

Substances

Antirheumatic Agents
Biological Products